ES-481 for Uncontrolled Glioma-Associated Epilepsy and Assessment for Potential Anti-Tumorigenic Effect in Patients With Isocitrate Dehydrogenase 1 (IDH1) Mutant Tumors
Clinical trial NCT04737174 · WITHDRAWN
Trial details
- NCT number
- NCT04737174
- Sponsor
- ES Therapeutics Australia Pty Ltd
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-25
- Primary completion
- 2021-10-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.